A detailed history of Tiemann Investment Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Tiemann Investment Advisors, LLC holds 11,136 shares of ABBV stock, worth $1.94 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
11,136
Previous 11,136 -0.0%
Holding current value
$1.94 Million
Previous $2.03 Million 5.77%
% of portfolio
0.85%
Previous 0.91%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $19,178 - $21,852
120 Added 1.09%
11,136 $2.03 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $43,344 - $48,815
-315 Reduced 2.78%
11,016 $1.71 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $6,679 - $7,732
50 Added 0.44%
11,331 $1.69 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $23,189 - $28,857
-175 Reduced 1.53%
11,281 $1.52 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $31,235 - $35,972
-216 Reduced 1.85%
11,456 $1.83 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $7,192 - $8,625
-52 Reduced 0.44%
11,672 $1.89 Million
Q3 2022

Nov 15, 2022

SELL
$134.21 - $153.93 $644,208 - $738,864
-4,800 Reduced 29.05%
11,724 $1.57 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $5,504 - $6,998
-40 Reduced 0.24%
16,524 $2.53 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $21,776 - $27,018
-165 Reduced 0.99%
16,564 $2.69 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $8,486 - $10,738
79 Added 0.47%
16,729 $2.27 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $27,238 - $30,919
-256 Reduced 1.51%
16,650 $1.8 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $15,781 - $17,581
-150 Reduced 0.88%
16,906 $1.9 Million
Q1 2021

May 11, 2021

BUY
$102.3 - $112.62 $126,545 - $139,310
1,237 Added 7.82%
17,056 $1.85 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $94,817 - $128,013
1,178 Added 8.05%
15,819 $1.7 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $23,539 - $27,627
-274 Reduced 1.84%
14,641 $1.28 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $18,929 - $25,330
258 Added 1.76%
14,915 $1.46 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $14,512 - $22,002
-225 Reduced 1.51%
14,657 $1.12 Million
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $18,032 - $22,562
-250 Reduced 1.65%
14,882 $1.32 Million
Q3 2019

Nov 15, 2019

SELL
$62.98 - $75.72 $58,760 - $70,646
-933 Reduced 5.81%
15,132 $1.15 Million
Q2 2019

Aug 13, 2019

SELL
$65.7 - $83.98 $26,280 - $33,592
-400 Reduced 2.43%
16,065 $1.17 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $19,929 - $24,578
256 Added 1.58%
16,465 $1.52 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $266 - $296
3 Added 0.02%
16,209 $1.53 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $38,156 - $45,147
-425 Reduced 2.56%
16,206 $1.5 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $29,903 - $40,043
325 Added 1.99%
16,631 $1.57 Million
Q4 2017

Feb 15, 2018

SELL
$89.56 - $98.21 $67,170 - $73,657
-750 Reduced 4.4%
16,306 $1.58 Million
Q2 2017

Aug 14, 2017

BUY
N/A
17,056
17,056 $1.24 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $308B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tiemann Investment Advisors, LLC Portfolio

Follow Tiemann Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiemann Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tiemann Investment Advisors, LLC with notifications on news.